These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30838819)

  • 1. Mouse strain differences in response to oral immunotherapy for peanut allergy.
    Wagenaar L; Bol-Schoenmakers MWHC; Giustarini G; Garssen J; Smit JJ; Pieters RHH
    Immun Inflamm Dis; 2019 Mar; 7(1):41-51. PubMed ID: 30838819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.
    Vonk MM; Wagenaar L; Pieters RHH; Knippels LMJ; Willemsen LEM; Smit JJ; van Esch BCAM; Garssen J
    Clin Transl Allergy; 2017; 7():35. PubMed ID: 29021893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
    Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
    J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy.
    Srivastava KD; Song Y; Yang N; Liu C; Goldberg IE; Nowak-Węgrzyn A; Sampson HA; Li XM
    Clin Exp Allergy; 2017 Aug; 47(8):1038-1049. PubMed ID: 28397379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Supplementation with Nondigestible Oligosaccharides Reduces Allergic Symptoms and Supports Low Dose Oral Immunotherapy in a Peanut Allergy Mouse Model.
    Wagenaar L; Bol-Schoenmakers M; Giustarini G; Vonk MM; van Esch BCAM; Knippels LMJ; Garssen J; Smit JJ; Pieters RHH
    Mol Nutr Food Res; 2018 Oct; 62(20):e1800369. PubMed ID: 30102006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing IgG
    Keswani T; LaHood NA; Marini-Rapoport O; Karmakar B; Andrieux L; Reese B; Sneed SL; Pedersen LC; Mueller GA; Patil SU
    J Allergy Clin Immunol; 2024 Jun; 153(6):1611-1620.e7. PubMed ID: 38460677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
    Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
    Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.
    Narisety SD; Frischmeyer-Guerrerio PA; Keet CA; Gorelik M; Schroeder J; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 2015 May; 135(5):1275-82.e1-6. PubMed ID: 25528358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy.
    Orgel K; Smeekens JM; Ye P; Fotsch L; Guo R; Miller DR; Pardo-Manuel de Villena F; Burks AW; Ferris MT; Kulis MD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1027-1037.e7. PubMed ID: 30342892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
    Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
    Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the Anaphylactic Response between C3H/HeOuJ and BALB/c Mice.
    Marco-Martín G; La Rotta Hernández A; Vázquez de la Torre M; Higaki Y; Zubeldia JM; Baeza ML
    Int Arch Allergy Immunol; 2017; 173(4):204-212. PubMed ID: 28850948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice.
    Morafo V; Srivastava K; Huang CK; Kleiner G; Lee SY; Sampson HA; Li AM
    J Allergy Clin Immunol; 2003 May; 111(5):1122-8. PubMed ID: 12743580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral immunotherapy treatment in severe IgE mediated milk, peanut, and egg allergy in adults.
    Mäntylä J; Thomander T; Hakulinen A; Kukkonen K; Palosuo K; Voutilainen H; Pelkonen A; Kauppi P
    Immun Inflamm Dis; 2018 Jun; 6(2):307-311. PubMed ID: 29542268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
    Vickery BP; Scurlock AM; Kulis M; Steele PH; Kamilaris J; Berglund JP; Burk C; Hiegel A; Carlisle S; Christie L; Perry TT; Pesek RD; Sheikh S; Virkud Y; Smith PB; Shamji MH; Durham SR; Jones SM; Burks AW
    J Allergy Clin Immunol; 2014 Feb; 133(2):468-75. PubMed ID: 24361082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice.
    Paolucci M; Homère V; Waeckerle-Men Y; Wuillemin N; Bieli D; Pengo N; Sonati T; Kündig TM; Johansen P
    Clin Exp Allergy; 2023 May; 53(5):550-560. PubMed ID: 36629248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response.
    Varshney P; Jones SM; Scurlock AM; Perry TT; Kemper A; Steele P; Hiegel A; Kamilaris J; Carlisle S; Yue X; Kulis M; Pons L; Vickery B; Burks AW
    J Allergy Clin Immunol; 2011 Mar; 127(3):654-60. PubMed ID: 21377034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.
    Gamazo C; García-Azpíroz M; Souza Rebouças J; Gastaminza G; Ferrer M; Irache JM
    Immunotherapy; 2017 Nov; 9(15):1205-1217. PubMed ID: 29130802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.